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A child with neonatal lupus was evaluated and found 
to possess serum anti Ro(SSA) antibodies. The cutaneous 
lesions and anti Ro(SSA) antibodies disappeared during 
the next 5 mo. 
The infant's mother was asymptomatic but possessed 
anti Ro(SSA) and anti La(SSB) antibodies. 
Neonatal lupus erythematosus is a rare, transient, inflam-
matory syndrome characterized by annular skin lesions clini-
cally and histopathologically typical of lupus erythematosus [1-
10]. Systemic manifestations including cardiac conduction de-
fects and organomegly also have been reported in some cases 
[11-17]. 
Despite the clinical features of lupus erythematosus, these 
infants often fail to demonstrate the serological abnormalities 
classically associated with systemic lupus erythematosus. For 
example, in a recent report summarizing the laboratory data of 
23 neonatal lupus patients, only 9 infants demonstrated a pos-
itive antinuclear antibody (ANA) test or a lupus erythematosus 
(LE) cell preparation [1]. 
Thus, these infants resemble a group of adult patients with 
clinical manifestations of systemic lupus erythematosus, includ-
ing prominent cutaneous features, who frequently fail to dem-
onstrate a positive ANA especially when mouse liver is em-
ployed as a substrate. These patients, however, possess anti 
Ro(SSA) and La(SSB) antibodies [18-22]. 
We report here an ANA negative infant with typical neonatal 
lupus who possessed the Ro(SSA) antibody system. The child's 
ANA negative, asymptomatic mother demonstrated anti 
Ro(SSA) and La(SSB) antibodies. 
CASE REPORT 
A black female, the product of an uncomplicated full-term pregnancy, 
labor, and delivery, was noted to have mottled periorbital hypopigmen-
tation at 10 days of age. Subsequently, the family also noted the 
appearance of widespread discrete, annular, erythematous, cutaneous 
lesions. Despite apparent good health and maintenance of growth at 
the 25th percentile level, the child continued to develop large annular 
erythematous skin lesions during the fU'st 2 mo of life. 1% hydrocorti-
sone cream was applied to the lesions without significant improvement. 
At 3'/, mo of age, the patient was fU'st seen by a dermatologist who 
noted multiple erythematous, minimally elevated, annular lesions with 
central hypopigmentation and a peripheral scale (Fig 1) distributed 
over the scalp, face, ears, trunk, and extremities. The remainder of the 
physical examination was unremarkable. Specifically, no organomegly 
was detected. 
A skin biopsy was taken from a lesion on the thigh. Histological 
findings included mild hyperkeratosis, dilatation and plugging of hair 
follicles, marked epidermal atrophy, and necrosis (dyskeratosis) of 
individual keratinocytes (Fig 2). Basal vacuolization was prominent; in 
areas the vacuoles coalesced to form subepidermal clefts. The basement 
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membrane was not thickened. The edematous papillary dermis con-
tained large dilated blood vessels and a diffuse mononuclear infiltrate 
admixed with extravasated erythrocytes. A moderately dense lympho-
histiocytic infiltrate surrounded the vessels and appendages of the 
reticular dermis. The colloidal iron stain demonstrated increased dep-
osition of mucin between the collagen fibers in the upper and mid-
reticular dermis. 
Direct immunofluorescence of normal extensor forearm skin and a 
lesion on the left thigh were both negative for immunoglobulin (IgG, 
IgA, IgM) and complement (C3) deposition [23]. 
LABORATORY STUDIES 
Abnormal laboratory studies included a white blood cell count of 
11,400 per mm3 with 8% neutrophils, 82% lymphocytes, 1% monocytes 
and 9% atypical lymphocytes; serum glutamic oxaloacetic transaminase 
(SGOT) 96 IU/L (normal 37-43 IU/L); serum glutamic pyruvic trans-
aminase (SGPT) 64 IU I L (normal 0-54 lUl L). The following laboratory 
tests were either normal or negative: urinalysis, platelet count, eryth-
rocyte sedimentation rate, blood urea nitrogen, serum creatinine, total 
serum protein, quantitative serum immunoglobulins, complement (C3) 
determination, rheumatoid factor, and syphilis serology. Hepatitis B 
surface antigen and antibody were not detected. A chest x-ray and 
electrocardiogram were normal. 
A test for antinuclear antibody using mouse liver substrate was 
negative. Single-stranded DNA employing Farr assay utilizing 1,25 DNA 
was 19.2% (normal <25%). Anti-native DNA determination employing 
immunofluorescent techniques and Crithidea luciliae were negative 
[24]. Precipitin antibodies utilizing calf thymic and human spleen 
extracts revealed a precipitin line against human spleen extract. This 
precipitin line gave a line of immunologic identity in gel double diffusion 
with a reference serum containing antibodies against the macromole-
cule Ro(SSA) [25,26]. (Fig 3) . No anti La(SSB), nRNP or Sm antibodies 
could be detected [27,28]. 
TREATMENT AND COURSE 
The topical hydrocortisone cream therapy was continued and over 
a period of 6 weeks the inflammatory lesions gradually faded, leaving 
residual hypopigmentation and hyperpigmentation. The child has con-
tinued to do well and growth markers have increased to the 50th 
percentile level. 
Repeat laboratory tests obtained at age 8 mo revealed the SGPT 
and SGOT to be within normal limits. The antinuclear antibody deter-
mination remained negative and the Ro(SSA) precipitin antibody was 
no longer detected in the infant's serum. 
The infant's mother is 27 yr old and has been in good health. She 
gave a history of a prior single spontaneous abortion at 3 mo. No 
examination, however, was performed on the fetus. History and physical 
examination of the mother was completely unremarkable. Specifically 
she denied fever. chills, chest pains, arthralgias, arthritis, and dryness 
of her eyes and mouth. Laboratory investigations which were negative 
or normal included: complete blood count (CBC) and differential, 
urinalysis, rheumatoid factor, antinuclear antibody (mouse liver sub-
strate), anti-native DNA and anti-single-stranded DNA studies. The 
mother did, however, demonstrate anti Ro(SSA) and La(SSB) anti-
bodies on gel double diffusion (Fig 3). Direct immunofluorescence 
studies on a biopsy of the normal extensor forearm skin was negative 
for IgG, IgA, IgM, or C3 deposition. Repeat studies 5 mo later demon-
strated persistence of anti Ro(SSA) and La(SSB) antibodies. As a 
control, the sera of 20 healthy pregnant women were studied for 
precipitins; all were negative. 
DISCUSSION 
Clark, Reichlin, and Tomasi in 1969 first described a precip-
itin antibody system Ro, which was reactive against a human 
spleen extract; they further characterized the antigen as a 
nonnucleic acid macromolecule [25]. This reference serum was 
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FIG 1. Circinate lesion on left forearm with minimally elevated 
border and irregular pigmentation. 
FIG 2. Lesion from the thigh showing hyperkeratosis, epidermal 
atroph.¥, basal vacuolization, dermal edema, superficial and deep peri-
vascular mononuclear cell infIltrate (hematoxylin-eosin, x 20) Inset. 
Higher magnification of epidermis and dermal-epidermal junction. (x 
200). 
derived from a patient with an unusual lupus~like syndrome. 
Subsequent experience has shown that the precipitin Ro occurs 
almost exclusively in patients with collagen vascular diseases. 
The prevalence of Ro in clinically normal members of a recent 
survey population was only 0.1% [29]. 
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Though less well studied, the precipitin La(SSB) described 
by Mattioli and Reichlin [26], also appears to be quite specific 
for a collagen vascular disease [28,30-34]. 
Development of a coherent global perspective on the exact 
significance of Ro and La in the diagnosis and assessment of 
autoimmune diseases has been hampered somewhat by several 
methodological difficulties. Firstly, only highly selected groupS 
of patients have been studied. Secondly, (particularly with 
regard to Ro), several antigen substrates have been employed, 
and these may vary in sensitivity [25,32]. Such variations in 
methods may be responsible for some of the discordant findings 
published to date [28]. Nevertheless, a number of important 
associations are emerging: 
1. Anti Ro antibodies are found in approximately 25% of 
ANA positive SLE patients [29-31], particularly in those pa-
tients with prominent cutaneous features [18,20-22]. Some of 
these latter patients have been termed subacute cutaneous 
lupus erythematosus [20,21]' A large group ofRo positive, ANA 
negative (mouse liver) lupus patients have now been described 
[22]. Skin fmdings are prominent in this latter group as well, 
particularly a photo-sensitivity-type malar rash. Save for the 
absence of ANA, many of these patients satisfy the ARA criteria 
for the diagnosis of SLE. In particular, some have had signifi-
cant renal disease. 
2. Forty to forty-five percent of patients with Sjogren's syn-
drome demonstrate Ro [29,31-34]' Some of this work was 
reported as demonstrative of the precipitin SSA; recent work 
has shown that reference sera for Ro and SSA give a reaction 
of identity [28]. (Neither mother nor infant described in this 
report had symptoms or physical findings of the sicca complex.) 
3. The antibody system La is found in approximately 10% of 
SLE patients and in a variable percentage of patients with 
Sjogren's syndrome [31,27]' The precipitin antibody SSB de-
scribed by Alspaugh and Tan has been shown to have immu-
nologic identity with La [28]. 
4. Ro (SSA) antibodies appear to have a strong association 
with neonatal lupus erythematosus. Weston et al have recently 
presented data on 3 neonatal lupus patients [35,36]. These 
patients are quite 'similar in many respects to the child pre-
sented here. As in our patient, the annular inflammatory skin 
lesions cleared within 6 mo, and the anti Ro and/or anti La 
antibodies disappeared. This suggests that the autoantibodies 
FIG 3. Gel double diffusion. Well #1 Ro positive control; #2 
Mother's serum; #3 Baby's serum; #4 Ro positive control; #5 Mother's 
serum; #6 human spleen extract. Note lines of immunologic identity 
between the baby's, the mother's and the Ro positive control sera. 
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in the babies' sera. were of maternal ongm. Also, as in the 
current case, Weston's experience demonstrates that the moth-
ers of the affected infants may be asymptomatic-2 out of 3 in 
his series [35]. 
In addition, we have had the opportunity to evaluate the 
serum and amniotic fluid obtained from a 20 week abortus 
(terminated for anencephaly and complete heart block) . The 
mother, a known systemic lupus patient, demonstrated serum 
anti Ro (SSA) and anti La (SSB) antibodies. The amniotic 
fluid, but not the baby's serum, also contained these antibodies. 
(Note that the majority of maternal antibodies cross the pla-
centa in the 3rd trimester of pregnancy. Our failure to detect 
the Ro antibody in a 20-week-old fetus may reflect insensitivity 
of the testing procedure.) 
The current case is the first to document Ro as the sole 
evident immunologic marker for neonatal lupus. Usually either 
ANA or RF or both have also been present [1,35,36]. 
This last observation further supports Weston's proposal that 
the anti Ro (SSA) antibody is a marker for the neonatal lupus 
syndrome [35]. The anti Ro antibodies provide a serologic link 
between these unusual neonatal lupus patients and the more 
typical SLE patients. Finally, this case report and the experi-
ence of Weston et al raises the possibility that autoantibodies 
may be causally related to the cutaneous lesions seen in this 
syndrome [35]. 
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